In an industry first, Proteintech has unveiled Able AI, an artificial intelligence (AI) platform designed specifically to assist scientists in selecting research reagents and optimizing experimental ...

Proteintech, announced the launch of Able AI, a first-of-its-kind artificial intelligence tool that is now available on (ptglab.com). This capability reduces guesswork and trial-and-error, enabling ...

ROSEMONT, Ill., September 02, 2025--(BUSINESS WIRE)--Proteintech, a global leader in antibodies and life science solutions, today announced the launch of Able AI, a first-of-its-kind artificial ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies When using antibodies in research or ...

SAN DIEGO--(BUSINESS WIRE)--Proteintech Genomics, a leader in antibody-based multiplexed solutions for single-cell multiomics, today announced the launch of its MultiPro® Human Discovery Panel, a ...

The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several ...

Proteintech Genomics, a subsidiary of Proteintech Group, inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiPro ™ Human Fixed Cell ...

SAN DIEGO--(BUSINESS WIRE)-- Proteintech Genomics, a subsidiary of Proteintech Group, Inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the ...

Background: Diabetic nephropathy (DN) is one of the leading causes of chronic kidney disease (CKD) worldwide, tubular injury is the driving force during the pathogenesis and progression of DN. Thus, ...